U.S. Markets close in 5 hrs 20 mins

Peregrine Pharmaceuticals, Inc. (PPHM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.130+0.050 (+1.623%)
As of 10:34AM EDT. Market open.
People also watch
GALETHLDCTICXOMACYTR

Peregrine Pharmaceuticals, Inc.

14282 Franklin Avenue
Tustin, CA 92780
United States
714-508-6000
http://www.peregrineinc.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees319

Key Executives

NameTitlePayExercisedAge
Mr. Steven W. KingCEO, Pres, Director, CEO of Avid Bioservices Inc and Pres of Avid Bioservices Inc933.04kN/A53
Mr. Paul J. Lytle CPAChief Financial Officer596.58kN/A49
Mr. Mark R. Ziebell J.D.VP, Gen. Counsel and Corp. Sec.481.68kN/A53
Dr. Shelley P. M. Fussey Ph.D.VP of Intellectual Property407.18kN/A51
Mr. Joseph S. Shan M.P.H.VP of Clinical & Regulatory Affairs473.38kN/A44
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate is bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy, and support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; and Lonza Biologics, as well as collaboration agreement with National Comprehensive Cancer Network, AstraZeneca PLC, and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.

Corporate Governance

Peregrine Pharmaceuticals, Inc.’s ISS Governance QualityScore as of August 1, 2017 is 8. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.